메뉴 건너뛰기




Volumn 56, Issue 1, 2012, Pages 300-301

Smoking and NASH: A hidden message from the GREACE trial

Author keywords

[No Author keywords available]

Indexed keywords

LIVER ENZYME;

EID: 83555168302     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.05.016     Document Type: Letter
Times cited : (3)

References (2)
  • 1
    • 79952701706 scopus 로고    scopus 로고
    • Nonalcoholic Steatohepatitis Clinical Research Network. Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease.
    • C.O. Zein, A. Unalp, R. Colvin, Y.C. Liu, and A.J. McCullough Nonalcoholic Steatohepatitis Clinical Research Network. Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. J Hepatol 54 2011 753 759
    • (2011) J Hepatol , vol.54 , pp. 753-759
    • Zein, C.O.1    Unalp, A.2    Colvin, R.3    Liu, Y.C.4    McCullough, A.J.5
  • 2
    • 78649890465 scopus 로고    scopus 로고
    • Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: A post-hoc analysis
    • V.G. Athyros, K. Tziomalos, and T.D. Gossios Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis Lancet 376 2010 1916 1922
    • (2010) Lancet , vol.376 , pp. 1916-1922
    • Athyros, V.G.1    Tziomalos, K.2    Gossios, T.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.